Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
Clinical trial NCT04314843 · TERMINATED
Trial details
- NCT number
- NCT04314843
- Sponsor
- Kite, A Gilead Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2021-03-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.